NASDAQ
Advanced Proteome Therapeutics Corporation (APTCF) has a free cash flow growth of -487.79% as of Friday, May 29, 2026. This represents a 4587.41% decrease compared to its 12-month average of -10.41%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.